Izotropic Corporation (OTCMKTS:IZOZF – Free Report) – Equities research analysts at Zacks Research issued their FY2026 earnings per share estimates for shares of Izotropic in a research report issued on Thursday, July 30th. Zacks Research analyst B. Sorensen anticipates that the company will earn $0.03 per share for the year. Zacks Research also issued estimates for Izotropic’s Q4 2026 earnings at $0.02 EPS, Q1 2027 earnings at $0.01 EPS, Q2 2027 earnings at $0.01 EPS, Q3 2027 earnings at $0.02 EPS, Q4 2027 earnings at $0.04 EPS and FY2027 earnings at $0.08 EPS.
Izotropic Trading Down 3.6%
IZOZF opened at $0.18 on Friday. Izotropic has a one year low of $0.12 and a one year high of $0.37. The business’s 50-day simple moving average is $0.18 and its 200-day simple moving average is $0.18.
Izotropic Company Profile
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.
See Also
- Five stocks we like better than Izotropic
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Izotropic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Izotropic and related companies with MarketBeat.com's FREE daily email newsletter.
